Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Non-narcotic treatment for migraines

28.12.2004


An inexpensive, non-narcotic medication has been identified as an important step in treating acute migraine headaches, according to a study performed by University of Alberta researchers in collaboration with other emergency physicians.



Researchers from the University of Alberta, University of Cambridge, Michigan State University and British Columbia’s St. Paul’s Hospital are recommending metoclopramide be considered a primary step in treating migraine sufferers who visit the emergency room for treatment.

The medication differs from traditional approaches such as narcotics (morphine or Demerol), because it avoids the risk of addiction to painkillers, noted Dr. Brian Rowe, a professor of emergency medicine at the University of Alberta.


"There is a tendency for patients with migraines to become dependent on narcotics for acute pain relief. Unfortunately, narcotics may reduce the pain acutely, however, they are sedating, usually with adverse effects, are usually not very effective and many patients suffer headache relapses that result in returns to the emergency room for additional care," Dr. Rowe said. "We recommend metoclopramide because it is safe, inexpensive and leads to less dependence on narcotics."

While metoclopramide has previously been used to treat migraines, the evidence was conflicting and this review by Rowe and his fellow researchers has helped clarify approaches for adult patients seeking headache relief in an emergency setting.

Results of the study, which involved reviewing data from 13 trials involving 655 adults, were published this month in the British Medical Journal. In studies comparing metoclopramide with placebos, the medication was 2.8 times more likely to provide significant reduction in migraine. In addition, combination treatments that included metoclopramide were as, or more effective than comparison treatments for migraine pain, nausea and relapse outcomes reported in all studies reviewed by the researchers.

Administered intravenously, metoclopramide proved effective in relieving the nausea that often accompanies a migraine, worked rapidly, was gentle on the stomach and did not cause changes in blood pressure.

Bev Betkowski | EurekAlert!
Further information:
http://www.ualberta.ca

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

Im Focus: Using graphene to create quantum bits

In the race to produce a quantum computer, a number of projects are seeking a way to create quantum bits -- or qubits -- that are stable, meaning they are not much affected by changes in their environment. This normally needs highly nonlinear non-dissipative elements capable of functioning at very low temperatures.

In pursuit of this goal, researchers at EPFL's Laboratory of Photonics and Quantum Measurements LPQM (STI/SB), have investigated a nonlinear graphene-based...

Im Focus: Bacteria harness the lotus effect to protect themselves

Biofilms: Researchers find the causes of water-repelling properties

Dental plaque and the viscous brown slime in drainpipes are two familiar examples of bacterial biofilms. Removing such bacterial depositions from surfaces is...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

Innovation 4.0: Shaping a humane fourth industrial revolution

17.05.2017 | Event News

 
Latest News

Scientists propose synestia, a new type of planetary object

23.05.2017 | Physics and Astronomy

Zap! Graphene is bad news for bacteria

23.05.2017 | Life Sciences

Medical gamma-ray camera is now palm-sized

23.05.2017 | Medical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>